{"id":1158,"date":"2014-11-06T01:05:01","date_gmt":"2014-11-06T01:05:01","guid":{"rendered":"http:\/\/www.symphonytg.com\/?p=1158"},"modified":"2014-11-06T01:05:01","modified_gmt":"2014-11-06T01:05:01","slug":"evidera-to-give-55-presentations-at-ispor-european-congress-the-most-of-any-attending-company","status":"publish","type":"post","link":"https:\/\/stg.com\/news\/evidera-to-give-55-presentations-at-ispor-european-congress-the-most-of-any-attending-company\/","title":{"rendered":"Evidera to Give 55 Presentations at ISPOR European Congress, the Most of Any Attending Company"},"content":{"rendered":"<p><a href=\"http:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.evidera.com%2F&amp;esheet=50975058&amp;newsitemid=20141105005119&amp;lan=en-US&amp;anchor=Evidera&amp;index=1&amp;md5=64c193e3fc053b153923aa52db63cde3\" target=\"_blank\" rel=\"nofollow noopener\">Evidera<\/a>, the global leader in health economics, outcomes research, market access, data analytics and epidemiology solutions, will participate in 55 presentations \u2014 the most of any attending company \u2014 at the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 17th\u00a0Annual European Congress, Nov. 8-12, in Amsterdam, Netherlands.<\/p>\n<p><p>\n<span style=\"line-height: 1.5em;\">With approximately one third of its staff based in Europe, Evidera is committed to being the scientific and methodological leader in Europe. At ISPOR\u2019s European Congress, Evidera will share examples of how it has contributed to the way products are delivered to patients in short courses, workshops, poster presentations and forums, including:<\/span><\/p>\n<ul>\n<li>Kevin Marsh, PhD, senior research scientist, European director of modeling: \u201c<a href=\"http:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.ispor.org%2FEvent%2FProgramList%2F2014Amsterdam%3Ftype%3DWorkshop%23WorkshopVI&amp;esheet=50975058&amp;newsitemid=20141105005119&amp;lan=en-US&amp;anchor=Supporting+Decision+Making+with+MCDA%3A+Recommendations+for+Dealing+with+Uncertainty&amp;index=2&amp;md5=13d20027f20aca6ac79cf02b41fc9796\" target=\"_blank\" rel=\"nofollow noopener\">Supporting Decision Making with MCDA: Recommendations for Dealing with Uncertainty<\/a>\u201d<\/li>\n<li>Yingxin Xu, PharmD, PhD, research scientist: \u201c<a href=\"http:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.ispor.org%2FEvent%2FProgramList%2F2014Amsterdam%3Ftype%3DWorkshop%23WorkshopV&amp;esheet=50975058&amp;newsitemid=20141105005119&amp;lan=en-US&amp;anchor=How+an+Early+Network+Meta-analysis+%28NMA%29+Helps+Inform+Clinical+Trials+Design+and+Technology+Appraisal+%28TA%29+Submissions&amp;index=3&amp;md5=1a252e1da98a18b08f5c00f7b2807719\" target=\"_blank\" rel=\"nofollow noopener\">How an Early Network Meta-analysis (NMA) Helps Inform Clinical Trials Design and Technology Appraisal (TA) Submissions<\/a>\u201d<\/li>\n<\/ul>\n<p>\n\u201cWe are investing considerable resources in developing novel methods and offerings that help our clients optimize the commercial success of their products in Europe,\u201d said Jon Williams, Evidera president and CEO. \u201cCongratulations and thank you to our clients and the many scientists and consultants at Evidera who are leading the innovation in our field and were involved in developing the 55 presentations for the ISPOR European Congress.\u201d<\/p>\n<p>\nAttending members of the Evidera European leadership team include:<\/p>\n<ul>\n<li>Rados\u0142aw (Radek) Wasiak, PhD, MA, MSc, executive director and senior research scientist in health economics<\/li>\n<li>Nick Sullivan, senior vice president, payer communications<\/li>\n<li>Margaret K. Vernon, PhD, senior research scientist, European director, outcomes research<\/li>\n<li>Kevin Marsh, PhD, senior research scientist, European director of modeling<\/li>\n<li>Xavier Badia, MD, MPH, PhD, senior research scientist, European senior lead market development<\/li>\n<\/ul>\n<p>\nView a\u00a0<a href=\"http:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.evidera.com%2Fconferences-presentations%2F%3Fevent_id1%3D120&amp;esheet=50975058&amp;newsitemid=20141105005119&amp;lan=en-US&amp;anchor=complete+list&amp;index=4&amp;md5=e697be99f496bd4b5ac2382cc11e8863\" target=\"_blank\" rel=\"nofollow noopener\">complete list<\/a>\u00a0of presentations and visit Booth 700 at ISPOR\u2019s European Congress to learn more about Evidera.<\/p>\n<p>\n<b>About Evidera<\/b><\/p>\n<p>\n<a href=\"http:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.evidera.com%2F&amp;esheet=50975058&amp;newsitemid=20141105005119&amp;lan=en-US&amp;anchor=Evidera&amp;index=5&amp;md5=2f47e66485e29725a4cbb53ef742e325\" target=\"_blank\" rel=\"nofollow noopener\">Evidera<\/a>, a wholly owned subsidiary of\u00a0<a href=\"http:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.symphonytg.com%2F&amp;esheet=50975058&amp;newsitemid=20141105005119&amp;lan=en-US&amp;anchor=Symphony+Technology+Group&amp;index=6&amp;md5=3efb22a065703945ac4c659218546b3b\" target=\"_blank\" rel=\"nofollow noopener\">Symphony Technology Group<\/a>, is one of the preeminent commercial entities analyzing effectiveness, establishing evidence and substantiating the value of treatments within the global health industry through its market-leading portfolio of health economics, outcomes research, market access, data analytics and epidemiology services. Evidera partners with life sciences organizations worldwide to optimize the market access and commercial success of their products by leveraging unparalleled knowledge of the global payer and regulator landscape and by developing, capturing and communicating the clinical and economic evidence that clients require to successfully market their products. Our research and consulting services are driven by world-class science and thought leadership and leverage a unique combination of capabilities. Visit\u00a0<a href=\"http:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.evidera.com&amp;esheet=50975058&amp;newsitemid=20141105005119&amp;lan=en-US&amp;anchor=www.evidera.com&amp;index=7&amp;md5=d269522a4c419728136d9e59e12f1274\" target=\"_blank\" rel=\"nofollow noopener\">www.evidera.com<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Evidera, the global leader in health economics, outcomes research, market access, data analytics and epidemiology solutions, will participate in 55 presentations \u2014 the most of any attending company \u2014 at the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 17th\u00a0Annual European Congress, Nov. 8-12, in Amsterdam, Netherlands. With approximately one third of its staff based&hellip;<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"node_moved":[],"footnotes":""},"categories":[5,10],"tags":[],"company":[],"class_list":["post-1158","post","type-post","status-publish","format-standard","hentry","category-news","category-press-release"],"acf":[],"yoast_head":"\n<title>Evidera to Give 55 Presentations at ISPOR European Congress, the Most of Any Attending Company - STG<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/stg.com\/news\/evidera-to-give-55-presentations-at-ispor-european-congress-the-most-of-any-attending-company\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Evidera to Give 55 Presentations at ISPOR European Congress, the Most of Any Attending Company - STG\" \/>\n<meta property=\"og:description\" content=\"Evidera, the global leader in health economics, outcomes research, market access, data analytics and epidemiology solutions, will participate in 55 presentations \u2014 the most of any attending company \u2014 at the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 17th\u00a0Annual European Congress, Nov. 8-12, in Amsterdam, Netherlands. With approximately one third of its staff based&hellip;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/stg.com\/news\/evidera-to-give-55-presentations-at-ispor-european-congress-the-most-of-any-attending-company\/\" \/>\n<meta property=\"og:site_name\" content=\"STG\" \/>\n<meta property=\"article:published_time\" content=\"2014-11-06T01:05:01+00:00\" \/>\n<meta name=\"author\" content=\"Gloria Consola\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Gloria Consola\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/stg.com\/news\/evidera-to-give-55-presentations-at-ispor-european-congress-the-most-of-any-attending-company\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/stg.com\/news\/evidera-to-give-55-presentations-at-ispor-european-congress-the-most-of-any-attending-company\/\"},\"author\":{\"name\":\"Gloria Consola\",\"@id\":\"https:\/\/stg.com\/#\/schema\/person\/d2ea413311d661450e19c0e000a9be8b\"},\"headline\":\"Evidera to Give 55 Presentations at ISPOR European Congress, the Most of Any Attending Company\",\"datePublished\":\"2014-11-06T01:05:01+00:00\",\"dateModified\":\"2014-11-06T01:05:01+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/stg.com\/news\/evidera-to-give-55-presentations-at-ispor-european-congress-the-most-of-any-attending-company\/\"},\"wordCount\":426,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/stg.com\/#organization\"},\"articleSection\":[\"News\",\"Press Release\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/stg.com\/news\/evidera-to-give-55-presentations-at-ispor-european-congress-the-most-of-any-attending-company\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/stg.com\/news\/evidera-to-give-55-presentations-at-ispor-european-congress-the-most-of-any-attending-company\/\",\"url\":\"https:\/\/stg.com\/news\/evidera-to-give-55-presentations-at-ispor-european-congress-the-most-of-any-attending-company\/\",\"name\":\"Evidera to Give 55 Presentations at ISPOR European Congress, the Most of Any Attending Company - STG\",\"isPartOf\":{\"@id\":\"https:\/\/stg.com\/#website\"},\"datePublished\":\"2014-11-06T01:05:01+00:00\",\"dateModified\":\"2014-11-06T01:05:01+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/stg.com\/news\/evidera-to-give-55-presentations-at-ispor-european-congress-the-most-of-any-attending-company\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/stg.com\/news\/evidera-to-give-55-presentations-at-ispor-european-congress-the-most-of-any-attending-company\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/stg.com\/news\/evidera-to-give-55-presentations-at-ispor-european-congress-the-most-of-any-attending-company\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/stg.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Evidera to Give 55 Presentations at ISPOR European Congress, the Most of Any Attending Company\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/stg.com\/#website\",\"url\":\"https:\/\/stg.com\/\",\"name\":\"STG\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/stg.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/stg.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/stg.com\/#organization\",\"name\":\"STG Partners, LLC\",\"url\":\"https:\/\/stg.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/stg.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/stg.com\/wp-content\/uploads\/2022\/03\/stg-logo-footer.svg\",\"contentUrl\":\"https:\/\/stg.com\/wp-content\/uploads\/2022\/03\/stg-logo-footer.svg\",\"width\":283,\"height\":132,\"caption\":\"STG Partners, LLC\"},\"image\":{\"@id\":\"https:\/\/stg.com\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/stg.com\/#\/schema\/person\/d2ea413311d661450e19c0e000a9be8b\",\"name\":\"Gloria Consola\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/stg.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/8f8b12d3166df48670d5c104f7739953?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/8f8b12d3166df48670d5c104f7739953?s=96&d=mm&r=g\",\"caption\":\"Gloria Consola\"}}]}<\/script>\n","yoast_head_json":{"title":"Evidera to Give 55 Presentations at ISPOR European Congress, the Most of Any Attending Company - STG","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/stg.com\/news\/evidera-to-give-55-presentations-at-ispor-european-congress-the-most-of-any-attending-company\/","og_locale":"en_US","og_type":"article","og_title":"Evidera to Give 55 Presentations at ISPOR European Congress, the Most of Any Attending Company - STG","og_description":"Evidera, the global leader in health economics, outcomes research, market access, data analytics and epidemiology solutions, will participate in 55 presentations \u2014 the most of any attending company \u2014 at the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 17th\u00a0Annual European Congress, Nov. 8-12, in Amsterdam, Netherlands. With approximately one third of its staff based&hellip;","og_url":"https:\/\/stg.com\/news\/evidera-to-give-55-presentations-at-ispor-european-congress-the-most-of-any-attending-company\/","og_site_name":"STG","article_published_time":"2014-11-06T01:05:01+00:00","author":"Gloria Consola","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Gloria Consola","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/stg.com\/news\/evidera-to-give-55-presentations-at-ispor-european-congress-the-most-of-any-attending-company\/#article","isPartOf":{"@id":"https:\/\/stg.com\/news\/evidera-to-give-55-presentations-at-ispor-european-congress-the-most-of-any-attending-company\/"},"author":{"name":"Gloria Consola","@id":"https:\/\/stg.com\/#\/schema\/person\/d2ea413311d661450e19c0e000a9be8b"},"headline":"Evidera to Give 55 Presentations at ISPOR European Congress, the Most of Any Attending Company","datePublished":"2014-11-06T01:05:01+00:00","dateModified":"2014-11-06T01:05:01+00:00","mainEntityOfPage":{"@id":"https:\/\/stg.com\/news\/evidera-to-give-55-presentations-at-ispor-european-congress-the-most-of-any-attending-company\/"},"wordCount":426,"commentCount":0,"publisher":{"@id":"https:\/\/stg.com\/#organization"},"articleSection":["News","Press Release"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/stg.com\/news\/evidera-to-give-55-presentations-at-ispor-european-congress-the-most-of-any-attending-company\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/stg.com\/news\/evidera-to-give-55-presentations-at-ispor-european-congress-the-most-of-any-attending-company\/","url":"https:\/\/stg.com\/news\/evidera-to-give-55-presentations-at-ispor-european-congress-the-most-of-any-attending-company\/","name":"Evidera to Give 55 Presentations at ISPOR European Congress, the Most of Any Attending Company - STG","isPartOf":{"@id":"https:\/\/stg.com\/#website"},"datePublished":"2014-11-06T01:05:01+00:00","dateModified":"2014-11-06T01:05:01+00:00","breadcrumb":{"@id":"https:\/\/stg.com\/news\/evidera-to-give-55-presentations-at-ispor-european-congress-the-most-of-any-attending-company\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/stg.com\/news\/evidera-to-give-55-presentations-at-ispor-european-congress-the-most-of-any-attending-company\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/stg.com\/news\/evidera-to-give-55-presentations-at-ispor-european-congress-the-most-of-any-attending-company\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/stg.com\/"},{"@type":"ListItem","position":2,"name":"Evidera to Give 55 Presentations at ISPOR European Congress, the Most of Any Attending Company"}]},{"@type":"WebSite","@id":"https:\/\/stg.com\/#website","url":"https:\/\/stg.com\/","name":"STG","description":"","publisher":{"@id":"https:\/\/stg.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/stg.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/stg.com\/#organization","name":"STG Partners, LLC","url":"https:\/\/stg.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/stg.com\/#\/schema\/logo\/image\/","url":"https:\/\/stg.com\/wp-content\/uploads\/2022\/03\/stg-logo-footer.svg","contentUrl":"https:\/\/stg.com\/wp-content\/uploads\/2022\/03\/stg-logo-footer.svg","width":283,"height":132,"caption":"STG Partners, LLC"},"image":{"@id":"https:\/\/stg.com\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/stg.com\/#\/schema\/person\/d2ea413311d661450e19c0e000a9be8b","name":"Gloria Consola","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/stg.com\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/8f8b12d3166df48670d5c104f7739953?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/8f8b12d3166df48670d5c104f7739953?s=96&d=mm&r=g","caption":"Gloria Consola"}}]}},"_links":{"self":[{"href":"https:\/\/stg.com\/wp-json\/wp\/v2\/posts\/1158"}],"collection":[{"href":"https:\/\/stg.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/stg.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/stg.com\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/stg.com\/wp-json\/wp\/v2\/comments?post=1158"}],"version-history":[{"count":0,"href":"https:\/\/stg.com\/wp-json\/wp\/v2\/posts\/1158\/revisions"}],"wp:attachment":[{"href":"https:\/\/stg.com\/wp-json\/wp\/v2\/media?parent=1158"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/stg.com\/wp-json\/wp\/v2\/categories?post=1158"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/stg.com\/wp-json\/wp\/v2\/tags?post=1158"},{"taxonomy":"company","embeddable":true,"href":"https:\/\/stg.com\/wp-json\/wp\/v2\/company?post=1158"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}